Lénaïg Tanneau, Ph.D.



  • Joined Pharmetheus in 2022, actively working in client projects
  • Expertise includes QTc modeling and pharmacometrics in therapeutic areas such as infectious diseases and oncology
  • Previously worked as pharmacometrician at Ipsen, France, as contract researcher at Uppsala University in collaboration with Merck KGaA, and as temporary MIDD Consultant at Pharmetheus, Sweden
  • M.Sc. in Pharmacokinetics (2014) from Paris Descartes University, France, Pharm.D. (2015) from University of Nantes, France, and Ph.D. in Pharmacometrics (2022) from Uppsala University, Sweden
LinkedInGoogle Scholar

Pharmetheus affiliated publications

Use of informative prior distributions from mepolizumab data to support depemokimab PKPD model analysis